Flavopiridol's Interaction with MRP1
Author Information
Author(s): Hooijberg J H, Broxterman H J, Scheffer G L, Vrasdonk C, Heijn M, Jong M C de, Scheper R J, Lankelma J, Pinedo HM
Primary Institution: Academisch Ziekenhuis Vrije Universiteit
Hypothesis
Flavopiridol interacts with MRP1 and affects the accumulation of daunorubicin in cancer cells.
Conclusion
Flavopiridol significantly increases daunorubicin accumulation in certain cancer cells, which may aid in developing anticancer therapies.
Supporting Evidence
- Flavopiridol stimulates the ATPase activity of MRP1 in a dose-dependent manner.
- A specific monoclonal antibody against MRP1 inhibits the ATPase activity induced by flavopiridol.
- Flavopiridol is the only compound tested that affects daunorubicin accumulation at concentrations below 1 μM.
- Glycosylated (iso)flavonoids do not affect MRP1-mediated transport or ATPase activity.
Takeaway
Flavopiridol helps cancer drugs get into cells better, which could make them work more effectively.
Methodology
The study involved testing the interaction of flavopiridol with MRP1 and measuring its effects on ATPase activity and drug accumulation in specific cell lines.
Limitations
The study primarily focuses on specific cell lines and may not represent all cancer types.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website